Previous 10 | Next 10 |
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application PR Newswire BETHESDA, Md. , Aug. 29, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company ...
2023-08-17 16:56:25 ET Summary Northwest Biotherapeutics is a biotech focused on developing a dendritic cell vaccine to fight cancer. The company has faced financial challenges and has relied on dilution to raise funds. While they have achieved success in glioblastoma, funding...
2023-04-30 04:06:29 ET Summary NWBO continues to slog away, with no definite date of a BLA submission. They recently made provisions for a large dilution, took a "toxic" loan, and got a manufacturing approval in the UK. There's progress, but it is agonizingly slow, and the sto...
2023-03-21 06:51:52 ET Northwest Biotherapeutics ( OTCQB:NWBO ) and Advent BioServices said that the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) approved and issued a MIA license to commercially manufacture cell therapy products at the GMP facility in Sa...
Northwest Biotherapeutics and Advent BioServices Announce Receipt of License for Commercial Manufacturing at Sawston, U.K. Facility PR Newswire One of the First UK Licenses for Commercial Manufacturing of Cell Therapy Products; Allows Global Delivery of the Products ...
Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB PR Newswire BETHESDA, Md. , March 11, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® personalized ...
2023-03-09 06:49:58 ET Cancer-focused biotech Northwest Biotherapeutics ( OTCQB:NWBO ) has entered into a loan agreement worth more than $11.0M with Utah-based Streeterville Capital LLC. Per the terms, the deal has a maturity of 22 months, and debt repayments will begin from N...
Summary The company does not offer a specific BLA filing date. They filed a major lawsuit against big name market makers, alleging stock price manipulation. NWBO has no cash. I see I am the only one covering Northwest Biotherapeutics ( NWBO ) on Seeking Alpha these day...
Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews 2022 Progress and Looks Forward to Strong 2023 PR Newswire 78% Of All Shares Were Voted; Proposals Received ≥90% of Votes Cast BETHESDA, Md. , Jan. 6, 2023 /PRNewswire/ -...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Northwest Biotherapeutics (OTCMKTS: NWBO ) are in focus on Thursday. NWBO stock is up about 5% on the day and it’s got investors’ attention with a lawsuit against Citadel Securities, among other fi...
News, Short Squeeze, Breakout and More Instantly...
Northwest Biotherapeutics Inc. Company Name:
NWBO Stock Symbol:
OTCMKTS Market:
Northwest Biotherapeutics Inc. Website:
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors PR Newswire BETHESDA, Md. , March 21, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® ...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...